(±)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats

被引:89
作者
Morley, KC [1 ]
McGregor, IS [1 ]
机构
[1] Univ Sydney, Dept Psychol, Sydney, NSW 2006, Australia
基金
澳大利亚研究理事会;
关键词
MDMA ((+/-)-3,4-methylenedioxymethamphetamine); ecstasy; anxiety; odor; cat; social interaction; ultrasonic vocalization;
D O I
10.1016/S0014-2999(00)00749-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of experiments administered a low dose range (0, 1.25, 2.5 and 5 mg/kg) of(+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') to rats and assessed them in a variety of standard tests of anxiety. These tests included the emergence and elevated plus-maze tests, social interaction, cat odor avoidance and footshock-induced ultrasonic vocalizations. MDMA increased anxiety-related behaviours in the emergence and elevated plus-maze tests at all dose levels. A 5 mg/kg dose of MDMA also significantly reduced the rime spent in close proximity to an anxiogenic cat odor stimulus. The 5 mg/kg dose also significantly reduced footshock-induced ultrasonic vocalizations. In the social interaction test, MDMA decreased aggressive behaviours at all doses tested, while the highest dose (5 mg/kg) also significantly increased the duration of social interaction. These results indicate that MDMA has both anxiogenic and anxiolytic effects depending upon the test situation employed. The facilitation of social interaction produced by MDMA in rats concurs with human experience of MDMA as a uniquely prosocial drug. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:41 / 49
页数:9
相关论文
共 54 条
[1]  
Bhattacharya SK, 1998, BIOGENIC AMINES, V14, P217
[2]  
Blanchard R. J., 1989, BIOL PSYCHIAT, V13, pS3
[3]   MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks [J].
Boot, BP ;
McGregor, LS ;
Hall, W .
LANCET, 2000, 355 (9217) :1818-1821
[4]   Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment [J].
Broocks, A ;
Briggs, NC ;
Pigott, TA ;
Hill, JL ;
Canter, SK ;
Tolliver, TJ ;
Baldemore, D ;
Murphy, DL .
PSYCHOPHARMACOLOGY, 1997, 130 (02) :91-103
[5]   ANTIPSYCHOTIC AGENTS ANTAGONIZE NONCOMPETITIVE N-METHYL-D-ASPARTATE ANTAGONIST-INDUCED BEHAVIORS [J].
CORBETT, R ;
CAMACHO, F ;
WOODS, AT ;
KERMAN, LL ;
FISHKIN, RJ ;
BROOKS, K ;
DUNN, RW .
PSYCHOPHARMACOLOGY, 1995, 120 (01) :67-74
[6]   PRELIMINARY-REPORT OF A SIMPLE ANIMAL BEHAVIOR MODEL FOR THE ANXIOLYTIC EFFECTS OF BENZODIAZEPINES [J].
CRAWLEY, J ;
GOODWIN, FK .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (02) :167-170
[7]   THE ANTINOCICEPTIVE EFFECTS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) IN THE RAT [J].
CRISP, T ;
STAFINSKY, JL ;
BOJA, JW ;
SCHECHTER, MD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1989, 34 (03) :497-501
[8]   Intracranial self stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol [J].
Depoortere, R ;
Perrault, G ;
Sanger, DJ .
PSYCHOPHARMACOLOGY, 1999, 142 (03) :221-229
[9]   SHOCK-INDUCED ULTRASONIC VOCALIZATION IN YOUNG-ADULT RATS - A MODEL FOR TESTING PUTATIVE ANTI-ANXIETY DRUGS [J].
DEVRY, J ;
BENZ, U ;
SCHREIBER, R ;
TRABER, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (03) :331-339
[10]   Low-dose midazolam attenuates predatory odor avoidance in rats [J].
Dielenberg, RA ;
Arnold, JC ;
McGregor, IS .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1999, 62 (02) :197-201